Notification Date: June 25th 2025
As part of QPharma’s ongoing commitment to supporting life sciences, we are providing this important regulatory update from the Vermont Attorney General’s Office regarding the Guide to Vermont’s Prescribed Products Gift Ban and Disclosure Law for 2025 data submissions, which are due April 1, 2026.
Key Legislative Changes – Effective July 1, 2025
The Vermont legislature recently passed 2025 Act 27, which introduces the following updates to the reporting requirements under 18 V.S.A. §§ 4631a–4632:
- Annual Fee Increase
The annual registration fee for manufacturers of prescribed products will increase from $500 to $765. This fee must be submitted by April 1, 2026, for companies with expenditures in calendar year 2025 - Processing Fee Responsibility
Processing fees will now be paid directly by the payor, rather than being billed to the Office of the Attorney General
Ongoing Compliance Requirements
In addition to the fee changes, manufacturers must continue to:
- Register with the Attorney General’s Office annually if they have any expenditures or sample distributions to Vermont health care providers.
- Submit disclosures of allowable expenditures and samples by the April 1 deadline.
- Complete a Compliance Officer Form before submitting disclosures. This form provides login credentials for the online submission portal
The Vermont law bans most gifts and requires reporting of nearly all expenditures related to pharmaceutical products, biological products, and medical devices. This includes samples (such as vouchers and starter packs), clinical trial payments, and certain educational or training-related expenses.
QPharma’s Support
QPharma will continue to work closely with each client to manage annual registration and fee submissions. We will provide reminders and guidance at the appropriate time to ensure full compliance with Vermont’s updated requirements.
Additional Information
This alert is for informational purposes only. The full guide and submission instructions can be accessed directly from the Vermont Attorney General’s website:
👉 View the Guide
About QPharma
QPharma services include regulatory strategy transparency reporting, state disclosure laws, and compliance operations to the life science industry. For more information or to discuss your requirements contact QPharma
